Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merkel cell carcinoma
Pharma
Incyte's PD-1 approved to treat rare cancer
After a prior rejection in another cancer type, Incyte's Zynyz finally scored an approval in Merkel cell carcinoma.
Zoey Becker
Mar 22, 2023 6:20pm
Merck's Keytruda pressures Bavencio with Merkel cell approval
Dec 20, 2018 9:57am
Pfizer, Merck KGaA nab NICE's favor for Bavencio
Mar 2, 2018 12:07pm
PD-L1 Bavencio from Pfizer and Merck KGaA grabs new EU approval
Sep 21, 2017 12:50pm
Pfizer, Merck score FDA nod for cancer fighter avelumab
Mar 23, 2017 4:55pm
